Alpine Immune Sciences Inc

NASDAQ:ALPN   3:59:43 PM EDT
9.94
+0.10 (+1.02%)
Other Pre-Announcement

Alpine Immune Sciences Reports Q3 Rev Of $1.9 Mln

Published: 11/12/2020 21:22 GMT
Alpine Immune Sciences Inc (ALPN) - Alpine Immune Sciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update.
Q3 Revenue $1.9 Million Versus $300,000.
Q3 Revenue Estimate $16.1 Million -- Refinitiv Ibes Data (analyst estimates).
Alpine Immune Sciences - Expects Current Cash Resources Are Sufficient to Fund Planned Operations Into 2024.